Previous Article | Next Article 
Infection and Immunity, November 1998, p. 5350-5356, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Complement Activation in Relation to Capillary
Leakage in Children with Septic Shock and Purpura
Jan A.
Hazelzet,1,*
Ronald
de Groot,2
Gerard
van Mierlo,3
Koen F. M.
Joosten,1
Edwin
van
der Voort,1
Anke
Eerenberg,3
Marja H.
Suur,2
Wim C. J.
Hop,4 and
C. Erik
Hack3
Divisions of Pediatric Intensive
Care,1 and
Pediatric Infectious Diseases
and Immunology,2 Department of Pediatrics,
Sophia Children's Hospital/University Hospital Rotterdam, and
Department of Biostatistics and Epidemiology, Erasmus
University, Rotterdam,4 and
Central Laboratory
of The Netherlands Red Cross Blood Transfusion Services and
Department of Internal Medicine, University Hospital VU,
Amsterdam,3 The Netherlands
Received 30 March 1998/Returned for modification 17 June
1998/Accepted 24 August 1998
To assess the relationship between capillary leakage and
inflammatory mediators during sepsis, blood samples were taken
on hospital admission, as well as 24 and 72 h later, from 52 children (median age, 3.3 years) with severe meningococcal sepsis, of
whom 38 survived and 14 died. Parameters related to cytokines
(interleukin 6 [IL-6] IL-8, plasma phospholipase
A2, and C-reactive protein [CRP]), to neutrophil
degranulation (elastase and lactoferrin), to complement
activation (C3a, C3b/c, C4b/c, and C3- and C4-CRP complexes), and to
complement regulation (functional and inactivated C1 inhibitor and
C4BP) were determined. The degree of capillary leakage was derived from
the amount of plasma infused and the severity of disease by assessing
the pediatric risk of mortality (PRISM) score. Levels of IL-6, IL-8,
C3b/c, C3-CRP complexes, and C4BP on admission, adjusted for the
duration of skin lesions, were significantly different in survivors and
nonsurvivors (C3b/c levels were on average 2.2 times higher in
nonsurvivors, and C3-CRP levels were 1.9 times higher in survivors).
Mortality was independently related to the levels of C3b/c and C3-CRP
complexes. In agreement with this, levels of complement activation
products correlated well with the PRISM score or capillary leakage.
Thus, these data show that complement activation in patients with
severe meningococcal sepsis is associated with a poor outcome and a
more severe disease course. Further studies should reveal whether
complement activation may be a target for therapeutical intervention in
this disease.
*
Corresponding author. Mailing address: Division of
Pediatric Intensive Care, Department of Pediatrics, Sophia Children's
Hospital/University Hospital Rotterdam, P.O. Box 2060, 3000-CB
Rotterdam, The Netherlands. Phone: (31) 104636363. Fax: (31) 104636796. E-mail: hazelzet{at}alkg.azr.nl.
Infection and Immunity, November 1998, p. 5350-5356, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hellerud, B. C., Stenvik, J., Espevik, T., Lambris, J. D., Mollnes, T. E., Brandtzaeg, P.
(2008). Stages of Meningococcal Sepsis Simulated In Vitro, with Emphasis on Complement and Toll-Like Receptor Activation. Infect. Immun.
76: 4183-4189
[Abstract]
[Full Text]
-
Schroth, M., Plank, C., Meissner, U., Eberle, K.-P., Weyand, M., Cesnjevar, R., Dotsch, J., Rascher, W.
(2006). Hypertonic-Hyperoncotic Solutions Improve Cardiac Function in Children After Open-Heart Surgery. Pediatrics
118: e76-e84
[Abstract]
[Full Text]
-
Sprong, T., Roos, D., Weemaes, C., Neeleman, C., Geesing, C. L. M., Mollnes, T. E., van Deuren, M.
(2006). Deficient alternative complement pathway activation due to factor D deficiency by 2 novel mutations in the complement factor D gene in a family with meningococcal infections. Blood
107: 4865-4870
[Abstract]
[Full Text]
-
Jarva, H., Ram, S., Vogel, U., Blom, A. M., Meri, S.
(2005). Binding of the Complement Inhibitor C4bp to Serogroup B Neisseria meningitidis. J. Immunol.
174: 6299-6307
[Abstract]
[Full Text]
-
Sprong, T., Moller, A.-S. W., Bjerre, A., Wedege, E., Kierulf, P., van der Meer, J. W. M., Brandtzaeg, P., van Deuren, M., Mollnes, T. E.
(2004). Complement Activation and Complement-Dependent Inflammation by Neisseria meningitidis Are Independent of Lipopolysaccharide. Infect. Immun.
72: 3344-3349
[Abstract]
[Full Text]
-
Sprong, T., Brandtzaeg, P., Fung, M., Pharo, A. M., Hoiby, E. A., Michaelsen, T. E., Aase, A., van der Meer, J. W. M., van Deuren, M., Mollnes, T. E.
(2003). Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis. Blood
102: 3702-3710
[Abstract]
[Full Text]
-
Zeerleder, S., Caliezi, C., van Mierlo, G., Eerenberg-Belmer, A., Sulzer, I., Hack, C. E., Wuillemin, W. A.
(2003). Administration of C1 Inhibitor Reduces Neutrophil Activation in Patients with Sepsis. CVI
10: 529-535
[Abstract]
[Full Text]
-
Kvalsvig, A J, Unsworth, D J
(2003). The immunopathogenesis of meningococcal disease. J. Clin. Pathol.
56: 417-422
[Abstract]
[Full Text]
-
Baines, P. B., Hart, C. A.
(2003). Severe meningococcal disease in childhood. Br J Anaesth
90: 72-83
[Abstract]
[Full Text]
-
Bosch, I., Xhaja, K., Estevez, L., Raines, G., Melichar, H., Warke, R. V., Fournier, M. V., Ennis, F. A., Rothman, A. L.
(2002). Increased Production of Interleukin-8 in Primary Human Monocytes and in Human Epithelial and Endothelial Cell Lines after Dengue Virus Challenge. J. Virol.
76: 5588-5597
[Abstract]
[Full Text]
-
Brandtzaeg, P., Bjerre, A., Ovstebo, R., Brusletto, B., Joo, G. B., Kierulf, P.
(2001). Invited review: Neisseria meningitidis lipopolysaccharides in human pathology. Innate Immunity
7: 401-420
[Abstract]
-
HACKETT, S.J., THOMSON, A.P. J., HART, C.A.
(2001). Cytokines, chemokines and other effector molecules involved in meningococcal disease. J Med Microbiol
50: 847-859
[Abstract]
[Full Text]
-
van Deuren, M., Brandtzaeg, P., van der Meer, J. W. M.
(2000). Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management. Clin. Microbiol. Rev.
13: 144-166
[Abstract]
[Full Text]
-
Schneider, D T, Nurnberger, W, Stannigel, H, Bonig, H, Gobel, U
(1999). Adjuvant treatment of severe acute pancreatitis with C1 esterase inhibitor concentrate after haematopoietic stem cell transplantation. Gut
45: 733-736
[Abstract]
[Full Text]